Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 50, Issue 10, Pages 3473-3475Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00479-06
Keywords
-
Categories
Ask authors/readers for more resources
Clostridium difficile isolates from a 2004 outbreak in Quebec, Canada, were all found to be susceptible to metronidazole, vancomycin, rifampin, and meropenem but resistant to bacitracin, cefotaxime, ciprofloxacin, and levofloxacin, and most (> 80%) were resistant to ceftriaxone, clarithromycin, gatifiloxacin, and moxifiloxacin. The predominant NAP1 isolates were susceptible to clindamycin, while the NAP2 isolates were resistant.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available